BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 24, 2011
View Archived Issues
PSMA-ADC appears safe in first-in-human study in taxane-refractory metastatic CRPC
Read More
Interim phase I data support safety of tremelimumab plus bicalutamide in recurrent prostate cancer
Read More
Intraprostatic administration of PROSTVAC VF cancer vaccine is feasible and safe
Read More
Zymes receives Michael J. Fox Foundation grant to assess WS-CoQ10 for Parkinson's disease
Read More
Tariquidar is safe in combination with docetaxel in patients with cancer
Read More
Shire reviews progress of fourth quarter 2010
Read More
Multistage tuberculosis vaccine H-56 combats late-stage infection in vivo
Read More
Vical and U.S. government extend collaboration to develop vaccines against emerging diseases
Read More
Eisai's warfarin potassium tablets approved in Japan for pediatric use
Read More
Novel tyrosine-protein kinase SYK inhibitors described by IRM
Read More
Laboratorios Salvat presents novel APAF-1 inhibitors
Read More
Dainippon Sumitomo Pharma reports on third quarter fiscal 2010
Read More
Roche presents novel P2X7 receptor modulators
Read More
Sun Pharma and Caraco enter merger agreement
Read More
Proacta and Yakult Honsha enter PR-509 development agreement
Read More
Nesina approved in Japan for additional indications in type 2 diabetes
Read More
New HSL inhibitors claimed
Read More
Stamford Hospital participates in FDA's Expanded Access program for Generex Oral-lyn
Read More
Elan and PPD form global drug development collaboration
Read More
Phase III Heplisav trials cleared by safety monitoring board to continue
Read More
Argon Pharma discovers new prostaglandin G/H synthase 2 inhibitors
Read More
Delcath Systems receives FDA refusal to file letter for chemosaturation system
Read More
Tranzyme Pharma and Norgine start phase III trial of ulimorelin for postoperative ileus
Read More
Japanese approval granted for Sosei's NorLevo emergency contraceptive pill
Read More
FDA grants fast track status to Sunesis' Vosaroxin in AML
Read More
